Black Diamond Therapeutics

investment firm

About

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.

Details

Last Funding Type
Series B
Last Funding Money Raised
$85M
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2017
Operating Status
Active
Stock Symbol
nasdaq:BDTX
Legal Name
Black Diamond Therapeutics, Inc.
Also Known As
Aset Therapeutics

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in discovering and developing small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, Mutation-Allostery-Pharmacology, which targets cancer mutations.

Black Diamond focuses on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes. It also targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$438.40M
Black Diamond Therapeutics has raised a total of $438.40M in funding over 2 rounds. Their latest funding was raised on Dec 29, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 29, 2022 Series Unknown $10M — — — Detail
Jan 29, 2020 IPO $231.30M — — — Detail
Dec 5, 2019 Series C $85M 13 Boxer Capital — Detail
Jan 9, 2019 Series B $85M 14 Boxer Capital
New Enterprise Associates
RA Capital Management
— Detail
Dec 12, 2018 Series A $20M 1 Versant Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
9
0
Black Diamond Therapeutics has made 9 investments. Their most recent investment was on Dec 12, 2022, when Launchpad Therapeutics raised $30M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $30M Life Science —
Feb 8, 2021 Goody
Seed $4M Consumer —
Mar 25, 2020 Helm.ai
Seed $13M Artificial Intelligence —
Apr 18, 2019 Fuzzbuzz
Seed $2.70M Developer Tools —
Aug 4, 2016 Elation Health
Series B $15M Electronic Health Record (EHR) —

Investors

Number of Lead Investors
Number of Investors
5
16
Black Diamond Therapeutics is funded by 16 investors. Boxer Capital and BVF Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Boxer Capital Yes Series C
BVF Partners — Series C
City Hill Ventures — Series C
Deepfield — Series C
Invus — Series C
Logos Capital — Series C
New Enterprise Associates — Series C
Nextech Invest — Series C
Perceptive Advisors — Series C
RA Capital Management — Series C

Employee Profiles

Number of Employee Profiles
8
Black Diamond Therapeutics has 8 current employee profiles, including Executive Alexander Mayweg
Executive
Executive
Board member
Executive